216 related articles for article (PubMed ID: 17442428)
21. Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy.
Ellims AH; Taylor AJ; Mariani JA; Ling LH; Iles LM; Maeder MT; Kaye DM
Circ Heart Fail; 2014 Mar; 7(2):271-8. PubMed ID: 24481111
[TBL] [Abstract][Full Text] [Related]
22. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
Tentolouris C; Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Trikas A; Toutouzas P; Stefanadis C
Int J Cardiol; 2004 Apr; 94(2-3):301-5. PubMed ID: 15093997
[TBL] [Abstract][Full Text] [Related]
23. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.
Santala M; Simojoki M; Risteli J; Risteli L; Kauppila A
Clin Cancer Res; 1999 Dec; 5(12):4091-6. PubMed ID: 10632345
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation.
Tziakas DN; Chalikias GK; Papanas N; Stakos DA; Chatzikyriakou SV; Maltezos E
Europace; 2007 Aug; 9(8):589-96. PubMed ID: 17485436
[TBL] [Abstract][Full Text] [Related]
25. Myocardial collagen turnover after surgical ventricular restoration in heart failure patients.
ten Brinke EA; Witkowski TG; Delgado V; Klein P; Klok M; Marsan NA; Klautz RJ; van der Wall EE; Bax JJ; van der Laarse A; Steendijk P
Eur J Heart Fail; 2011 Nov; 13(11):1202-10. PubMed ID: 21846755
[TBL] [Abstract][Full Text] [Related]
26. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis.
Klappacher G; Franzen P; Haab D; Mehrabi M; Binder M; Plesch K; Pacher R; Grimm M; Pribill I; Eichler HG
Am J Cardiol; 1995 May; 75(14):913-8. PubMed ID: 7733000
[TBL] [Abstract][Full Text] [Related]
27. Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy.
Ohtsuka T; Nishimura K; Kurata A; Ogimoto A; Okayama H; Higaki J
J Card Fail; 2007 Nov; 13(9):752-8. PubMed ID: 17996824
[TBL] [Abstract][Full Text] [Related]
28. Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion.
Kawamura M; Munetsugu Y; Kawasaki S; Onishi K; Onuma Y; Kikuchi M; Tanno K; Kobayashi Y
Europace; 2012 Dec; 14(12):1719-25. PubMed ID: 22622138
[TBL] [Abstract][Full Text] [Related]
29. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.
Kanoupakis EM; Manios EG; Kallergis EM; Mavrakis HE; Goudis CA; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
J Am Coll Cardiol; 2010 Jun; 55(24):2753-9. PubMed ID: 20538169
[TBL] [Abstract][Full Text] [Related]
30. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy.
Kaufman BD; Videon N; Zhang X; Harris MA; Shaddy RE; Goldmuntz E
Cardiol Young; 2015 Feb; 25(2):228-36. PubMed ID: 24192074
[TBL] [Abstract][Full Text] [Related]
31. Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.
Koivula MK; Ruotsalainen V; Björkman M; Nurmenniemi S; Ikäheimo R; Savolainen K; Sorva A; Risteli J
Ann Clin Biochem; 2010 Jan; 47(Pt 1):67-71. PubMed ID: 19940208
[TBL] [Abstract][Full Text] [Related]
32. [Interleukin-4 and cardiac fibrosis in patients with heart failure].
Roselló-Lletí E; Rivera M; Bertomeu V; Cortés R; Jordán A; González-Molina A
Rev Esp Cardiol; 2007 Jul; 60(7):777-80. PubMed ID: 17663863
[TBL] [Abstract][Full Text] [Related]
33. Chemotactic activity of serum obtained from patients with idiopathic dilated cardiomyopathy.
Sigusch HH; Lehmann MH; Reinhardt D; Henke A; Zell R; Leipner C; Figulla HR
Pharmazie; 2006 Aug; 61(8):706-9. PubMed ID: 16964715
[TBL] [Abstract][Full Text] [Related]
34. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
[TBL] [Abstract][Full Text] [Related]
35. Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy.
Del Ry S; Giannessi D; Maltinti M; Cabiati M; Prontera C; Iervasi A; Caselli C; Mazzone AM; Neglia D
Cytokine; 2010 Mar; 49(3):325-30. PubMed ID: 20031444
[TBL] [Abstract][Full Text] [Related]
36. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
[TBL] [Abstract][Full Text] [Related]
37. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
[TBL] [Abstract][Full Text] [Related]
38. Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy.
Bonapace S; Rossi A; Cicoira M; Golia G; Zanolla L; Franceschini L; Conte L; Marino P; Zardini P; Vassanelli C
Am Heart J; 2006 Jul; 152(1):93.e1-6. PubMed ID: 16824836
[TBL] [Abstract][Full Text] [Related]
39. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
40. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
